Clinical Trials
MGC Diagnostics Announces Clinical Study to Evaluate the Diagnostic Accuracy of FOT
MGC Diagnostics Corporation , a global medical technology company, today announced a new clinical study collaboration with Restech Srl to evaluate the diagnostic accuracy of the forced...
Clinical Trials
Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial
Inovio Pharmaceuticals, Inc. announced preliminary results from the expanded stage of its phase I study, EBOV-001. The expanded study examined different regimens of its Ebola...
Clinical Trials
Cytori Receives FDA Approval for Burn Clinical Trial Related to BARDA Contract
Cytori Therapeutics, Inc. announced that the U.S. FDA has approved an IDE for a pilot clinical trial to evaluate Cytori Cell Therapy™ in patients with...
Clinical Trials
Kiadis Pharma receives regulatory approval for next trials for ATIR101 and ATIR201
Kiadis Pharma N.V. , a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders announces that it has...
Clinical Trials
Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia
Selvita , a clinical stage drug discovery and development company focused on innovative medicines for patients with blood cancers, announced that the first patient was...
Clinical Trials
LEO Pharma announces positive results from phase 2b clinical study for tralokinumab in atopic dermatitis
LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic...
Clinical Trials
Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases
Inovio Pharmaceuticals, Inc. announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (GLS-5300) and Zika (GLS-5700)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.